Skip to content

Biozen Named Finalist in ACC 2026 Innovation Pitch Challenge

Press Release

Issued March 26, 2026, before the BP1000 received FDA 510(k) clearance on May 11, 2026.

Oklahoma City, OK — March 26, 2026

One of four companies selected to present at the American College of Cardiology Scientific Sessions in New Orleans

OKLAHOMA CITY, March 26, 2026 /PRNewswire/ --

Biozen, LLC has been selected as a finalist in the American College of Cardiology (ACC) Future Hub Innovation Pitch Challenge, taking place March 29 during the ACC Scientific Sessions (March 28–30, 2026) at the Ernest N. Morial Convention Center in New Orleans.

The Innovation Pitch Challenge highlights emerging noninvasive technologies shaping the future of cardiovascular care. Selected from a global pool, Biozen is one of four finalists who will present their technology before a panel of industry leaders at ACC.

Biozen’s technology enables absolute blood pressure measurement without the need for a cuff or calibration, addressing a longstanding challenge in cuffless blood pressure measurement and monitoring.

Using proprietary pressure and optical sensing in conjunction with physiologically-informed algorithms, Biozen’s ultra-compact BP1000 device, coupled with a companion app, directly measures blood pressure from the digital artery at the fingertip.

By capturing pressure at the moment of arterial occlusion, the platform delivers an absolute blood pressure measurement grounded in established physiology, evaluated against the clinical gold standard.

“Being selected as a finalist in the ACC Innovation Pitch Challenge is a meaningful milestone for our team,” said Dikran Tourian, Chief Executive Officer of Biozen. “We’re focused on expanding access to clinically reliable blood pressure measurement without the limitations of traditional cuffs, and we look forward to sharing how our technology can support that at scale.”

“ACC brings together clinicians, researchers, innovators and investors who are shaping the future of cardiovascular medicine,” said Omer Inan, PhD, Chief Scientific Officer of Biozen. “We look forward to presenting our approach to blood pressure measurement and the progress of our platform in the Innovation Pitch Challenge.”

Biozen will also present prospective clinical validation data at ACC, evaluating its device under the ISO 81060-2:2018 validation protocol.

About Biozen

Biozen, LLC is a privately held digital health company headquartered in Oklahoma City, Oklahoma, with research and development in Atlanta, Georgia. Biozen’s cuffless blood pressure platform, protected by more than 65 granted U.S. and international patents, integrates advanced biosensors with proprietary algorithms to deliver absolute, calibration-free blood pressure readings from the fingertip.

Note: The Biozen BP Sensor and BP1000 are investigational devices and are not yet cleared by the U.S. Food and Drug Administration (FDA) for commercial distribution.

For more information, visit biozen.com.

Media Contact

Ashley Wilson

press@biozen.com

+1 405-413-5201

Biozen

Redefining how the world measures blood pressure

Sign up to receive early access and updates

FDA Cleared1

  1. Biozen BP1000 has received FDA 510(k) clearance, the first cuffless blood pressure device cleared to deliver calibration-free, clinically validated spot measurement from the fingertip.

© 2026 Biozen, LLC. All rights reserved.

Privacy Policy

This privacy policy sets out how Biozen, LLC ("Biozen") uses and protects any information that you give to Biozen. Biozen is committed to ensuring that your privacy is protected. Should we ask you to provide certain information by which you can be identified when using this website, then you can be assured that it will only be used in accordance with this privacy statement. Biozen may change this policy from time to time by updating this page. You should check this page from time to time to ensure that you are happy with any changes.

What we retain

We may retain the following information:

  • Your name, email address and telephone number, and any message that you enter into the contact form
  • Other information that you provide to us

What we do with the information we retain

We require this information to understand your needs and provide you with a better service, including:

  • We may use the information to improve our products and services.
  • We may periodically send promotional emails about new products, special offers or other information which we think you may find interesting using the email address which you have provided.
  • From time to time, we may also use your information to contact you for market research purposes. We may contact you by email, phone, fax or mail. We may use the information to customise the website according to your interests.

Security

We are committed to ensuring that your information is secure. In order to prevent unauthorised access or disclosure we have put in place physical, electronic and managerial procedures to safeguard and secure the information we collect online.

Links to other websites

Our website may contain links to other websites of interest. However, once you have used these links to leave our site, you should note that we do not have any control over that other website. Therefore, we cannot be responsible for the protection and privacy of any information which you provide whilst visiting such sites and such sites are not governed by this privacy statement. You should exercise caution and look at the privacy statement applicable to the website in question.

Controlling your personal information

If you have agreed to us retaining and using your personal information, you may change your mind at any time using the contact form.

We will not sell, distribute or lease your personal information to third parties unless we have your permission or are required by law to do so. You may request details of personal information which we hold about you. If you would like a copy of the information held on you, please email info@biozen.com.

If you believe that any information we are holding on you is incorrect or incomplete, please write to us or use the contact form as soon as possible, at the above address. We will promptly correct any information found to be incorrect.

Biozen, LLC
7023 N. Classen Blvd., Oklahoma City, OK 73116